A transformational system for Whole Genome Sequencing has arrived at the NHS Exeter Genomics Laboratory, Research, Innovation, Learning & Development (RILD) building, marking a momentous moment for our research collaboration with the University of Exeter, the Exeter NIHR Biomedical Research Centre (BRC), and the NHS South West Genomic Laboratory Hub.

The new arrival is an Illumina NovaSeq X Plus, a cutting-edge genetic sequencer, that can look at almost all of an individual’s genetic information in a single test within 24 hours. The sequencer, provided by leading developer and manufacturer Illumina, made a grand entrance on Tuesday 22 August.

Once installed within the NHS Exeter Genomics Laboratory, the new technology will form an integral part of our dedicated joint NHS and university research facility.

With this pioneering sequencer, we will be able to deliver ground-breaking translational human genetic research, providing more diagnoses and improving clinical outcomes for NHS patients. The first of its kind in an NHS Trust. The new sequencer will also increase capacity and reduce costs revolutionising the way we conduct research and diagnostics.

The purchase of the Illumina NovaSeq X Plus was made possible thanks to the Royal Devon being awarded a significant investment of £2.179m, part of which has funded the acquisition of the sequencer. This follows the NIHR announcement that more than £96 million will be awarded to 93 NHS organisations across England. 

Our world-leading and award-winning translational genomic services are invaluable for patient and families affected by rare genetic conditions. We are excited to see the diagnostic service developments that will arise from this new investment.

Watch the moment the sequencer arrived here: